Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.460
-0.060 (-3.95%)
Feb 20, 2026, 4:00 PM EST - Market closed
Metagenomi Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.25
Upside
+533.56%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +379.45% | Aug 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +653.42% | Aug 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +721.92% | Aug 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +721.92% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $16 | Buy | Maintains | $20 → $16 | +995.89% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $7 | Strong Buy | Maintains | $14 → $7 | +379.45% | Apr 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +1,269.86% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $14 | Strong Buy | Maintains | $7 → $14 | +858.90% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +379.45% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +927.40% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +379.45% | Oct 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +379.45% | Sep 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +927.40% | Sep 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +379.45% | Aug 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +927.40% | Aug 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $22 → $17 | Buy | Maintains | $22 → $17 | +1,064.38% | Aug 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.